ANDERSON Strathern, one of Scotland’s most innovative, independent law firms, is reporting its most successful year ever for investment deals.
The corporate investment team, led by Euan Tripp, advises some of Scotland’s most active investors – spanning private equity funds, institutional investors, angel syndicates, family offices and high net worth individuals as well as universities and investment arms of large corporate organisations.
In 2022, the team has been involved in over 25 corporate investment deals with an aggregate value well in excess of £20 million.
The deals have been largely dominated by investments into tech companies across a variety of sectors but increasingly focused on renewable energy, marine and climate impact. Some highlights for the growing team include:
- an investment of £2.75 million in fintech company Aveni Ltd by Par Equity and Tricapital, alongside Scottish Enterprise
- a two-tranche investment of £1.6 million in medtech company Carcinotech Ltd, led by Tricapital, with co-investment from Scottish Enterprise, Gabriel Investments, EOS, Grampian Alba and SIS Ventures – illustrating the collaborative nature of the early-stage Scottish investment scene.
Euan Tripp, partner at Anderson Strathern, noted: “Despite the uncertainty and disruption during 2022, it has been a very positive year for investment deal activity at Anderson Strathern. Over the past year, we have acted for a growing number of institutional and private investors, as well as investee companies and universities, which continue to scale up academic ideas into spin-off companies. We continue to see technology and renewable energy companies attract substantial investments, which is encouraging in the face of macro-economic uncertainty.”
Max Scharbert, a senior director in Anderson Strathern’s corporate investment team commented: “We are cautiously optimistic for 2023 – existing investee companies are likely to require further funding rounds, and exciting new ideas will always attract capital. In our current financial climate, young companies are likely to face greater challenges in attracting funding and will need strong business cases to persuade more cautious investors. But overall, Scotland remains a very attractive option for investors looking to diversify their portfolios.”
